Higher BMI Raises Postoperative Mortality in Pancreatic Surgery
Overweight and obese patients face significantly higher postoperative mortality rates after pancreatic resection, spotlighting the need for careful patient selection.
Newsletter
HPB & Spleen
Every new paper in this field, in your inbox.
PANC Classification Improves Prognosis in Pancreatic Cancer
New insights on CA 19-9 dynamics can enhance treatment strategies for pancreatic cancer patients undergoing surgery.
Tailored Chemotherapy for Gallbladder Cancer: A Better Approach
A prognostic model for gallbladder cancer can refine adjuvant chemotherapy decisions and improve patient outcomes.
Trisectionectomies Enhance Outcomes in Bismuth Type II-III Cholangiocarcinoma
Trisectionectomies significantly improve survival for patients with localized Bismuth-Corlette type II-III perihilar cholangiocarcinoma.
Liver Resection for Colorectal Metastases Sets New Outcomes Benchmark
Liver resection remains a gold standard for colorectal liver metastases, providing critical data for patient selection and surgical outcomes.
New model predicts early recurrence risk in pancreatic tumors
Surgeons can now identify non-functioning pancreatic neuroendocrine tumors at high risk for early recurrence preoperatively.
New model predicts poor outcomes in liver surgery for HCC
Surgeons now have a validated model to identify patients at high risk for early non-curative recurrence after liver resection for hepatocellular carcinoma (HCC), crucial for tailoring postoperative care.
ICG Navigation Outperforms Conventional Technique for Hepatic Hemangioma
Using indocyanine green (ICG) fluorescence navigation in laparoscopic hepatectomy leads to better outcomes for hepatic hemangioma patients.
Surgical Resection Boosts Survival in HCC After Triple Therapy
Surgical resection significantly improves survival for hepatocellular carcinoma patients who reach complete response following triple therapy.
Predictive nomogram reduces futile surgery in gallbladder cancer
Surgeons can now better identify patients who may not benefit from surgery for gallbladder cancer.